NO168041C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.

Info

Publication number
NO168041C
NO168041C NO871870A NO871870A NO168041C NO 168041 C NO168041 C NO 168041C NO 871870 A NO871870 A NO 871870A NO 871870 A NO871870 A NO 871870A NO 168041 C NO168041 C NO 168041C
Authority
NO
Norway
Prior art keywords
erytromycin
preparation
acid esters
therapeutic active
retinic acid
Prior art date
Application number
NO871870A
Other languages
English (en)
Norwegian (no)
Other versions
NO871870L (no
NO871870D0 (no
NO168041B (no
Inventor
Michel Philippe
Henri Sebag
Didier Dupuis
Andre Rougier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of NO871870D0 publication Critical patent/NO871870D0/no
Publication of NO871870L publication Critical patent/NO871870L/no
Priority to NO910442A priority Critical patent/NO168647C/no
Publication of NO168041B publication Critical patent/NO168041B/no
Publication of NO168041C publication Critical patent/NO168041C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C07H15/16—Lincomycin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
NO871870A 1986-05-06 1987-05-05 Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin. NO168041C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO910442A NO168647C (no) 1986-05-06 1991-02-05 Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av lincomycin og clindamycin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8606528A FR2598420B1 (fr) 1986-05-06 1986-05-06 Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant

Publications (4)

Publication Number Publication Date
NO871870D0 NO871870D0 (no) 1987-05-05
NO871870L NO871870L (no) 1987-11-09
NO168041B NO168041B (no) 1991-09-30
NO168041C true NO168041C (no) 1992-01-08

Family

ID=9334966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871870A NO168041C (no) 1986-05-06 1987-05-05 Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.

Country Status (13)

Country Link
JP (1) JP2504990B2 (da)
BE (1) BE1004152A4 (da)
CA (1) CA1300131C (da)
CH (1) CH674847A5 (da)
DE (1) DE3714937C2 (da)
DK (1) DK169345B1 (da)
ES (1) ES2006478A6 (da)
FR (1) FR2598420B1 (da)
GB (1) GB2191483B (da)
IT (1) IT1204556B (da)
NL (1) NL193946C (da)
NO (1) NO168041C (da)
SE (1) SE470379B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87041A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87039A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters biaromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87036A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters cycloaliphatiques insatures d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87035A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters du type etretinique ou apparente d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87040A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87038A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters aromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87037A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
LU87070A1 (fr) * 1987-12-10 1989-07-07 Oreal Association de derives de pyrimidine et d'agents pour induire et stimuler la croissance des cheveux et diminuer leur chute
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
GB2282596B (en) * 1993-10-06 1998-04-15 Ciba Geigy Ag Water-soluble retinoids
FR2931662B1 (fr) * 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise.
FR2931661B1 (fr) * 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862921A (en) * 1953-08-13 1958-12-02 Upjohn Co Erythromycin esters
US3598806A (en) * 1969-04-15 1971-08-10 Upjohn Co Process for preparing lincomycin-3-monoacylates
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
FR2582000B1 (fr) * 1985-05-14 1987-06-26 Oreal Esters gras bi ou tri-eniques d'erythromycine a, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant

Also Published As

Publication number Publication date
DE3714937C2 (de) 1998-02-26
BE1004152A4 (fr) 1992-10-06
IT8720389A0 (it) 1987-05-05
CA1300131C (fr) 1992-05-05
JPS62289593A (ja) 1987-12-16
GB8710673D0 (en) 1987-06-10
JP2504990B2 (ja) 1996-06-05
NO871870L (no) 1987-11-09
SE8701845L (sv) 1987-11-07
DE3714937A1 (de) 1987-11-12
FR2598420B1 (fr) 1991-06-07
NL193946C (nl) 2001-03-02
FR2598420A1 (fr) 1987-11-13
NO871870D0 (no) 1987-05-05
DK229387A (da) 1987-11-07
SE8701845D0 (sv) 1987-05-05
DK229387D0 (da) 1987-05-05
IT1204556B (it) 1989-03-10
NL8701054A (nl) 1987-12-01
GB2191483B (en) 1990-05-30
SE470379B (sv) 1994-02-07
NL193946B (nl) 2000-11-01
DK169345B1 (da) 1994-10-10
CH674847A5 (da) 1990-07-31
GB2191483A (en) 1987-12-16
ES2006478A6 (es) 1989-05-01
NO168041B (no) 1991-09-30

Similar Documents

Publication Publication Date Title
NO171788C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fosfinsyrederivater
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO168041C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO170021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO171016C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.